FDA awards Novartis expanded approval for breast cancer therapy
Posted:
Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated only for patients with metastatic disease. But, the Food and Drug Administration approved Kisqali in combination with hormone therapy for patients with certain early-stage breast cancers.
The Swedish company Everdrone is launching a newly developed drone (E3) designed to enable both more frequent and faster deployments to emergency calls. The drone can also be equipped to carry both defibrillators and other emergency medical equipment.
Read more…
In the demanding environment of the NHS, asking staff to find extra time for exercise can feel like 1 more burden on an already stretched workforce – much like telling someone who’s burned out to simply be more resilient. Yet…
Attendees
Sponsors and Exhibitors
Contact us